Rituximab in anti-GBM disease: A retrospective study of 8 patients
- 1 June 2015
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 60, 74-79
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated VasculitisNew England Journal of Medicine, 2014
- Diagnosis and classification of Goodpasture's disease (anti-GBM)Journal of Autoimmunity, 2014
- Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patientsRheumatology, 2013
- Anti-Glomerular Basement Membrane DiseaseMedicine, 2011
- Update on antiglomerular basement membrane diseaseCurrent Opinion in Rheumatology, 2011
- Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM NephritisNew England Journal of Medicine, 2010
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- Clinical features and outcome of patients with both ANCA and anti-GBM antibodiesKidney International, 2004
- Goodpasture's diseaseThe Lancet, 2001
- Anti-glomerular basement membrane antibody-induced glomerulonephritisKidney International, 1973